Popular

Village Farms Cultivates in Netherlands; Tilray Medical Blooms in Germany
Stargazer Fest Unveils Epic 2026 Lineup!
Top Cannabis Strains Dominating US Market in June 2026
Trulieve’s NYSE Debut: A Cannabis First!
Taima Growth Secures Spain’s 4th Cannabis Cultivator License
Akanda Corp. Back on Nasdaq Track

Village Farms Cultivates in Netherlands; Tilray Medical Blooms in Germany

Village Farms International has announced the commencement of cultivation at its new Netherlands facility, marking a significant expansion for the company. Simultaneously, Tilray Medical has launched its first German-cultivated brand, signaling growth in the European medical cannabis market. Key Highlights: Village Farms International begins operations at a new cultivation site in the Netherlands. Tilray Medical…

Read More

Stargazer Fest Unveils Epic 2026 Lineup!

The much-anticipated Stargazer Cannabis Festival has officially announced its star-studded lineup for the June 12-14, 2026, event. This year’s festival promises an unforgettable experience with a diverse range of musical acts and cannabis-focused attractions. Headliners Announced: Major artists spanning multiple genres will take the main stage. Expanded Cannabis Village: Featuring a wider array of dispensaries,…

Read More

Top Cannabis Strains Dominating US Market in June 2026

The landscape of popular cannabis strains in the United States for June 2026 is marked by a continued demand for potent, flavorful, and consistently effective varieties. Consumers are increasingly seeking strains that offer specific effects, from deep relaxation to creative uplift, driving innovation and market trends. This year’s top contenders showcase a blend of classic…

Read More

Taima Growth Secures Spain’s 4th Cannabis Cultivator License

Taima Growth has officially become the fourth company to receive a coveted license from Spain’s Agency for Medicines and Health Products (AEMPS) to cultivate medical cannabis. This significant milestone positions Taima Growth as a key player in Spain’s burgeoning medicinal cannabis industry, opening doors for increased production and wider access to therapeutic cannabis products for…

Read More

Akanda Corp. Back on Nasdaq Track

Akanda Corp. has successfully regained compliance with Nasdaq’s periodic filing requirements, averting potential delisting. The pharmaceutical company submitted its overdue financial reports, satisfying the exchange’s stipulations and securing its position on the Nasdaq Capital Market. Akanda Corp. has met Nasdaq’s filing requirements. The company submitted its delinquent financial reports. This action prevents the potential delisting…

Read More

Pure Sunfarms’ Pink Kush Vape Hits Canadian Market

Pure Sunfarms has officially launched its highly anticipated Pink Kush Cured Resin Vape across Canada, offering consumers a new premium cannabis concentrate experience. New Pink Kush Cured Resin Vape now available. Features high-quality, full-spectrum cannabis. Focuses on authentic terpene profiles. Available in select Canadian provinces. A New Frontier in Cannabis Vaping The Canadian cannabis market…

Read More

FIFA Lawyers Target Bong Shop Over World Cup Merch

FIFA’s legal team has issued a demand to a Toronto smoke shop to cease selling a bong that allegedly resembles the World Cup trophy. The move highlights FIFA’s aggressive stance on protecting its intellectual property and brand association, even in seemingly unrelated markets. Key Highlights: A Toronto-based smoke shop is under fire from FIFA lawyers….

Read More

Ukraine Vets Get Medical Cannabis

A groundbreaking initiative has seen the first medical cannabis prescriptions issued to Ukrainian war veterans suffering from multiple sclerosis (MS). This marks a significant milestone in acknowledging and treating the complex health challenges faced by those who have served. Key Highlights: First medical cannabis prescriptions dispensed to Ukrainian war veterans with MS. Represents a new…

Read More

Germany Approves Exilby Cannabis; FDA Grants Breakthrough Therapy

Exilby, a whole plant botanical cannabis treatment, has received marketing authorization in Germany, marking a significant milestone in the acceptance of cannabis-based therapies in Europe. Concurrently, the United States Food and Drug Administration (FDA) has granted Exilby a Breakthrough Therapy Designation, a signal of the drug’s potential to treat serious conditions more effectively than existing…

Read More